| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caspases | 17 | 2014 | 679 | 2.280 |
Why?
|
| Apoptosis | 25 | 2016 | 7752 | 1.700 |
Why?
|
| Caspase 9 | 10 | 2016 | 187 | 1.520 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 9 | 2016 | 42 | 1.500 |
Why?
|
| Apoptosomes | 5 | 2016 | 12 | 1.440 |
Why?
|
| Caspase 3 | 10 | 2016 | 474 | 1.130 |
Why?
|
| Ubiquitin | 4 | 2014 | 331 | 1.110 |
Why?
|
| Hydrazones | 1 | 2024 | 42 | 0.890 |
Why?
|
| Inhibitor of Apoptosis Proteins | 6 | 2014 | 202 | 0.890 |
Why?
|
| Endosomes | 1 | 2024 | 105 | 0.870 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2014 | 592 | 0.850 |
Why?
|
| Mitochondrial Proteins | 8 | 2015 | 378 | 0.810 |
Why?
|
| Morpholines | 1 | 2024 | 296 | 0.810 |
Why?
|
| Lysosomes | 1 | 2024 | 345 | 0.760 |
Why?
|
| Hot Temperature | 2 | 2014 | 289 | 0.670 |
Why?
|
| Proteins | 10 | 2006 | 2043 | 0.580 |
Why?
|
| Ubiquitination | 4 | 2014 | 579 | 0.560 |
Why?
|
| Apoptosis Regulatory Proteins | 6 | 2014 | 622 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2012 | 1542 | 0.510 |
Why?
|
| Mitochondria | 9 | 2015 | 1298 | 0.510 |
Why?
|
| Caspase 6 | 1 | 2012 | 15 | 0.420 |
Why?
|
| Biopolymers | 1 | 2012 | 37 | 0.410 |
Why?
|
| Enzyme Precursors | 1 | 2012 | 71 | 0.410 |
Why?
|
| Hydroquinones | 3 | 2009 | 33 | 0.410 |
Why?
|
| Benzene | 3 | 2009 | 47 | 0.410 |
Why?
|
| Reactive Oxygen Species | 4 | 2015 | 1006 | 0.410 |
Why?
|
| Spermatogenesis | 1 | 2014 | 268 | 0.400 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2014 | 874 | 0.390 |
Why?
|
| Caspase 7 | 2 | 2009 | 30 | 0.380 |
Why?
|
| Pyrimidines | 1 | 2024 | 3666 | 0.380 |
Why?
|
| Ion Channels | 3 | 2015 | 235 | 0.380 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 2618 | 0.340 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2010 | 210 | 0.340 |
Why?
|
| Cytochromes c | 4 | 2012 | 117 | 0.340 |
Why?
|
| Proteolysis | 3 | 2014 | 377 | 0.300 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 8 | 2006 | 123 | 0.300 |
Why?
|
| Heat-Shock Response | 1 | 2007 | 41 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 809 | 0.290 |
Why?
|
| fas Receptor | 3 | 2003 | 197 | 0.280 |
Why?
|
| Peptides | 1 | 2012 | 1504 | 0.270 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 275 | 0.260 |
Why?
|
| Membrane Proteins | 3 | 2014 | 2929 | 0.260 |
Why?
|
| Drosophila melanogaster | 2 | 2013 | 866 | 0.260 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 906 | 0.250 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2003 | 207 | 0.250 |
Why?
|
| Carrier Proteins | 5 | 2006 | 2099 | 0.240 |
Why?
|
| Enzyme Activation | 5 | 2013 | 1811 | 0.230 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2024 | 45 | 0.230 |
Why?
|
| Endoplasmic Reticulum | 2 | 2006 | 328 | 0.230 |
Why?
|
| Keratinocytes | 2 | 2015 | 244 | 0.210 |
Why?
|
| Animals | 20 | 2016 | 62031 | 0.210 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 52 | 0.210 |
Why?
|
| Signal Transduction | 11 | 2014 | 12098 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2010 | 1280 | 0.200 |
Why?
|
| Caspase 8 | 3 | 2010 | 146 | 0.190 |
Why?
|
| Organelles | 1 | 2001 | 43 | 0.190 |
Why?
|
| Cell Line | 8 | 2009 | 5339 | 0.180 |
Why?
|
| Glutathione | 2 | 2000 | 375 | 0.180 |
Why?
|
| Sphingomyelins | 1 | 2000 | 28 | 0.180 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2014 | 288 | 0.180 |
Why?
|
| Caspase 2 | 2 | 2014 | 43 | 0.180 |
Why?
|
| Benzoquinones | 2 | 2011 | 110 | 0.160 |
Why?
|
| Models, Biological | 5 | 2014 | 3194 | 0.160 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2014 | 374 | 0.160 |
Why?
|
| Imidazoles | 1 | 2024 | 1064 | 0.150 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2012 | 80 | 0.150 |
Why?
|
| Sf9 Cells | 1 | 2016 | 15 | 0.140 |
Why?
|
| Spodoptera | 1 | 2016 | 81 | 0.140 |
Why?
|
| Phosphotransferases | 1 | 2016 | 82 | 0.140 |
Why?
|
| Dimerization | 1 | 2016 | 311 | 0.130 |
Why?
|
| Erythrocytes | 1 | 1997 | 337 | 0.130 |
Why?
|
| Caspase Inhibitors | 2 | 2007 | 95 | 0.130 |
Why?
|
| Humans | 29 | 2015 | 270631 | 0.120 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2014 | 70 | 0.110 |
Why?
|
| Intercellular Junctions | 1 | 2014 | 56 | 0.110 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 75 | 0.110 |
Why?
|
| Protein Structure, Quaternary | 3 | 2011 | 136 | 0.110 |
Why?
|
| Multienzyme Complexes | 4 | 2002 | 226 | 0.110 |
Why?
|
| Protein Conformation | 6 | 2011 | 1255 | 0.110 |
Why?
|
| Deoxyadenine Nucleotides | 3 | 2001 | 29 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 269 | 0.110 |
Why?
|
| Cell Death | 2 | 2014 | 686 | 0.110 |
Why?
|
| Mitochondrial Membranes | 1 | 2012 | 59 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2013 | 167 | 0.100 |
Why?
|
| Binding Sites | 3 | 2007 | 2255 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2016 | 902 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2013 | 581 | 0.100 |
Why?
|
| Permeability | 1 | 2012 | 160 | 0.100 |
Why?
|
| Models, Molecular | 5 | 2011 | 1742 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 476 | 0.100 |
Why?
|
| Bone Marrow | 2 | 2009 | 2438 | 0.100 |
Why?
|
| Lysine | 2 | 2011 | 426 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 4 | 2007 | 1472 | 0.090 |
Why?
|
| Testis | 1 | 2014 | 620 | 0.090 |
Why?
|
| Macromolecular Substances | 2 | 2001 | 340 | 0.090 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2010 | 6 | 0.090 |
Why?
|
| DNA Adducts | 1 | 2011 | 214 | 0.090 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2010 | 37 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 4569 | 0.090 |
Why?
|
| Sulfhydryl Compounds | 1 | 2009 | 70 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2015 | 1033 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 1901 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 344 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2073 | 0.080 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 2 | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2009 | 5697 | 0.070 |
Why?
|
| Nerve Endings | 1 | 2007 | 11 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2009 | 3586 | 0.070 |
Why?
|
| Median Eminence | 1 | 2007 | 10 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 322 | 0.070 |
Why?
|
| Mice | 5 | 2016 | 35586 | 0.070 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 3027 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 1431 | 0.070 |
Why?
|
| CRADD Signaling Adaptor Protein | 1 | 2006 | 5 | 0.070 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2006 | 26 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2007 | 169 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 1149 | 0.070 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2006 | 44 | 0.070 |
Why?
|
| Nucleotides | 1 | 2006 | 174 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2007 | 498 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 330 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 635 | 0.060 |
Why?
|
| Cell Survival | 2 | 2009 | 3062 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2007 | 877 | 0.060 |
Why?
|
| Copper | 1 | 2006 | 165 | 0.060 |
Why?
|
| Protein Transport | 1 | 2007 | 737 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 268 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 2 | 2002 | 262 | 0.060 |
Why?
|
| Phenol | 2 | 2009 | 18 | 0.060 |
Why?
|
| Uncoupling Protein 3 | 2 | 2015 | 9 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2010 | 2421 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 6686 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2453 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 303 | 0.050 |
Why?
|
| Flavoproteins | 1 | 2002 | 32 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 3341 | 0.050 |
Why?
|
| Protein Binding | 3 | 2007 | 3485 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2002 | 142 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 1503 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 351 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2012 | 4117 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2001 | 136 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2001 | 721 | 0.040 |
Why?
|
| Kidney | 1 | 2009 | 2119 | 0.040 |
Why?
|
| Phosphatidylserines | 1 | 2000 | 73 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 206 | 0.040 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 63 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2000 | 318 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2001 | 295 | 0.040 |
Why?
|
| Circular Dichroism | 2 | 2011 | 107 | 0.040 |
Why?
|
| Horses | 2 | 2011 | 99 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 1469 | 0.040 |
Why?
|
| Biological Transport | 1 | 2000 | 627 | 0.040 |
Why?
|
| Rats | 3 | 2009 | 6524 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 4889 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 2212 | 0.040 |
Why?
|
| Chromatography, Liquid | 2 | 2011 | 354 | 0.040 |
Why?
|
| Antibodies | 1 | 2001 | 809 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 1997 | 117 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 1095 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 14833 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 1585 | 0.030 |
Why?
|
| Phenols | 1 | 1997 | 106 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2011 | 387 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2001 | 1140 | 0.030 |
Why?
|
| Mutation | 2 | 2009 | 15911 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 80 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2015 | 248 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 1946 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2014 | 110 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2014 | 329 | 0.030 |
Why?
|
| Carcinogens | 1 | 2015 | 391 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 895 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 3656 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 271 | 0.030 |
Why?
|
| DNA Damage | 1 | 2001 | 1988 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 659 | 0.030 |
Why?
|
| Metabolome | 1 | 2015 | 355 | 0.030 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2012 | 38 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 5070 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 784 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 504 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 2011 | 52 | 0.020 |
Why?
|
| Epidermis | 1 | 2012 | 196 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 417 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 7913 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 1462 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2009 | 55 | 0.020 |
Why?
|
| Male | 3 | 2014 | 128316 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 3044 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2009 | 223 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2009 | 485 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 44 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 4223 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 206 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 338 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2007 | 136 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 399 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2006 | 175 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 606 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 1273 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2007 | 530 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 201 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 1217 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 16204 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 385 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 5759 | 0.010 |
Why?
|
| Gene Expression | 1 | 2012 | 3641 | 0.010 |
Why?
|
| Estradiol | 1 | 2007 | 828 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 1709 | 0.010 |
Why?
|
| Smad Proteins | 1 | 2003 | 82 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2003 | 143 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 7235 | 0.010 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2002 | 21 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 70 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 383 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2002 | 198 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 320 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 15909 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 788 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 3118 | 0.010 |
Why?
|
| Potassium | 1 | 2002 | 340 | 0.010 |
Why?
|
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 2000 | 6 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 701 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2002 | 604 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 768 | 0.010 |
Why?
|
| Etoposide | 1 | 2000 | 907 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 1624 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2003 | 1564 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 2220 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 5001 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 13017 | 0.000 |
Why?
|
| Female | 2 | 2009 | 148865 | 0.000 |
Why?
|